mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
-0.034 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |